A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors
about
Virus-like particles as quantitative probes of membrane protein interactionsSensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptorConformational antibody binding to a native, cell-free expressed GPCR in block copolymer membranesA simple detection method for low-affinity membrane protein interactions by baculoviral display.Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation.Use of Lentiviral Particles As a Cell Membrane-Based mFasL Delivery System for In Vivo Treatment of Inflammatory Arthritis.Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virusCD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated regionSingle-molecule analysis of human immunodeficiency virus type 1 gp120-receptor interactions in living cells.Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 bindingSensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kineticsSurvey of the year 2000 commercial optical biosensor literature.Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.Cell-free assay of G-protein-coupled receptors using fluorescence polarization.Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors.Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.Thermal green protein, an extremely stable, nonaggregating fluorescent protein created by structure-guided surface engineering.Nonantibody-based recognition: alternative molecules for detection of pathogens.Expression, surface immobilization, and characterization of functional recombinant cannabinoid receptor CB2Maturation of the Gag core decreases the stability of retroviral lipid membranes.Surface plasmon resonance applied to G protein-coupled receptors.CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptorExpression and characterization of a soluble, active form of the jaagsiekte sheep retrovirus receptor, Hyal2.Virus expression vectors.Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptorsProperties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones.Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusionImpact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity.Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes.The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.RMCE-based insect cell platform to produce membrane proteins captured on HIV-1 Gag virus-like particles.A combinatorial G protein-coupled receptor reconstitution system on budded baculovirus. Evidence for Galpha and Galphao coupling to a human leukotriene B4 receptor.Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles.
P2860
Q24657310-59789922-29DA-4EAE-8E9E-5B444D56A511Q28346124-66031B21-167C-46EF-ADEB-CD7CE083977AQ28543955-1DDB8300-38F9-4BC2-82F7-3B33E9ECC160Q33395661-18A2EA3E-046D-425F-9F6E-8876A3CDE773Q33504556-D675A5EB-6294-4A3D-BA3B-9D00C8BDFD80Q33586182-AC66CDFA-F3CA-48F4-873A-FEE79036188EQ33707328-23F3235A-9E92-4D5D-BDD0-A66CE07E9CE0Q33848876-11AC22D4-0336-47BE-8F63-4E30D98AFF3DQ33851913-FC431691-1152-4E60-B637-11410B9C82A7Q33870292-44954A22-6305-4F52-8BE3-5C67F837AA2AQ34142829-ABA295A7-CEAE-4716-A403-79FE8357F5DAQ34349528-B47494D3-B9A4-41CF-92CC-E31F9F0F113DQ34415921-82DB502C-5DC1-4056-AE92-CF324C1F2B64Q34464911-1394B8F5-3F1C-434E-9195-7016276CBF23Q34465007-C3299AC7-606D-4EC5-B15F-67A12B438F0DQ34756144-2E11AD34-7B6B-4F79-B615-B7D9C34C88A2Q34787797-65813627-1788-4C83-AAC7-B0EE9E044C45Q34864675-8F226BB3-D0A1-4DD8-9458-7EDE5E7E39CDQ35000106-92E886F8-2380-4144-822E-837EF1A53BA8Q35878870-EA4BE56B-E080-4FD5-A4D1-F943D5BD5E95Q36119188-669487B2-F6D4-4CAC-BCFB-4DAAC9880DD9Q36641466-2E9F40EB-FA4D-4D29-A419-C367D76406E0Q37187837-41097198-7959-4C59-A32E-8ADBEF2D126FQ37359745-ADB9250B-2CD6-4ECB-8AC2-883F6519FBDCQ37503485-4EA289D9-FA85-4E69-B41B-C85739AB922DQ37730009-5089A9C7-FD21-4B17-A796-4384184D58BDQ37746382-5E3FC8AD-DF6E-4805-866D-ACDA0A876008Q38226671-B3284F7A-1408-4630-9A7A-1F0FB56FC104Q39605336-3DABD8FB-2090-445C-93EA-95324BC77D82Q39682485-08AFD91F-1AD9-4C6D-8FEA-06917DD0527AQ39684388-49044EB9-BAE9-4B62-BD20-AEF7818A7DFDQ40384583-4D363E3B-B36A-4F8B-B169-24F95DE713A8Q40561855-17F90114-4886-4DE4-99C8-F78E15BBB09EQ40787903-F367778E-943D-4A64-AFC3-BCAD9088F9F1Q41345703-101CFCB5-D215-4ECB-A8CE-7F59F51D618DQ45324767-E4E4558B-8749-4628-A597-49EF3D104318Q51599885-E6C4BF5C-32AE-4966-963E-D6DCD2FD8DADQ53819033-C473A16E-8480-422E-A8C2-5C6BECEEE11D
P2860
A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A biosensor assay for studying ...... V-1 Env to chemokine receptors
@ast
A biosensor assay for studying ...... V-1 Env to chemokine receptors
@en
type
label
A biosensor assay for studying ...... V-1 Env to chemokine receptors
@ast
A biosensor assay for studying ...... V-1 Env to chemokine receptors
@en
prefLabel
A biosensor assay for studying ...... V-1 Env to chemokine receptors
@ast
A biosensor assay for studying ...... V-1 Env to chemokine receptors
@en
P2093
P2860
P356
P1476
A biosensor assay for studying ...... V-1 Env to chemokine receptors
@en
P2093
P2860
P304
11215-11220
P356
10.1073/PNAS.190274097
P407
P577
2000-10-01T00:00:00Z